Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M et al.. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 9: 218-224

Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
Nature Cell Biology (Impact Factor: 19.68). 03/2007; 9(2):218-24. DOI: 10.1038/ncb1537
Source: PubMed


Nutrients and bioenergetics are prerequisites for proliferation and survival of mammalian cells. We present evidence that the cyclin-dependent kinase inhibitor p27(Kip1), is phosphorylated at Thr 198 downstream of the Peutz-Jeghers syndrome protein-AMP-activated protein kinase (LKB1-AMPK) energy-sensing pathway, thereby increasing p27 stability and directly linking sensing of nutrient concentration and bioenergetics to cell-cycle progression. Ectopic expression of wild-type and phosphomimetic Thr 198 to Asp 198 (T198D), but not unstable Thr 198 to Ala 198 (p27(T198A)) is sufficient to induce autophagy. Under stress conditions that activate the LKB1-AMPK pathway with subsequent induction of autophagy, p27 knockdown results in apoptosis. Thus LKB1-AMPK pathway-dependent phosphorylation of p27 at Thr 198 stabilizes p27 and permits cells to survive growth factor withdrawal and metabolic stress through autophagy. This may contribute to tumour-cell survival under conditions of growth factor deprivation, disrupted nutrient and energy metabolism, or during stress of chemotherapy.

Download full-text


Available from: Dan Dumont, Sep 14, 2015
  • Source
    • "Phosphorylation of Thr 172 in AMPK (pAMPK) is required for AMPK activation, and serine/threonine kinase liver kinase B1 (LKB1) directly mediates this event [30] [31]. AMPK activity regulates the function of peroxisome proliferator-activated receptor-g coactivator 1a (PGC-1a), acetyl-Co A carboxylase (ACC1 and ACC2), glucose-transporter type 4 (GLUT4) and tuberous sclerosis complex (TSC)-2 in the metabolic process, cell growth and tumor progression [32]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Basic helix-loop-helix (bHLH) transcription factor DEC1 (bHLHE40/Stra13/Sharp2) is one of the clock genes that show a circadian rhythm in various tissues. AMP-activated protein kinase (AMPK) activity plays important roles in the metabolic process and in cell death induced by glucose depletion. Recent reports have shown that AMPK activity exhibited a circadian rhythm. However, little is known regarding the regulatory mechanisms involved in the circadian rhythm of AMPK activity. The aim of this study is to investigate whether there is a direct correlation between DEC1 expression and AMPK activity. DEC1 protein and AMPK activity showed a circadian rhythm in the mouse liver with different peak levels. Knocking down DEC1 expression increased AMPK activity, whereas overexpression of DEC1 decreased it. Overexpressing the DEC1 basic mutants had little effect on the AMPK activity. DEC1 bound to the E-box of the LKB1 promoter, decreased LKB1 activity and total protein levels. There was an inverse relationship between DEC1 expression and AMPK activity. Our results suggest that DEC1 negatively regulates AMPK activity via LKB1.
    Full-text · Article · Oct 2015 · Biochemical and Biophysical Research Communications
  • Source
    • "For example, as revealed in experiment [8], if the rate of autolysosome formation exceeds that of autophagosome formation, the steady-state concentration of autophagosomes could be detected less, leading to an underestimation of the autophagy status. Moreover, the autophagic process is regulated by the complex positive–negative feedback mechanism (see Figure 1): The output of the process, i.e., recycled amino acids and ATP, acts as the input of the system, which independently manipulates each of the steps in a concentration-dependent manner [9-14]. Such feedback loops may be beneficial for the delicate balance of the cellular homeostasis. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A number of cellular- and molecular-level studies of autophagy assessment have been carried out with the help of various biochemical and morphological indices. Still there exists ambiguity for the assessment of the autophagy status and of the causal relationship between autophagy and related cellular changes. To circumvent such difficulties, we probe new quantitative indices of autophagy which are important for defining autophagy activation and further assessing its roles associated with different physiopathological states. Our approach is based on the minimal autophagy model that allows us to understand underlying dynamics of autophagy from biological experiments. Specifically, based on the model, we reconstruct the experimental context-specific autophagy profiles from the target autophagy system, and two quantitative indices are defined from the model-driven profiles. The indices are then applied to the simulation-based analysis, for the specific and quantitative interpretation of the system. Two quantitative indices measuring autophagy activities in the induction of sequestration fluxes and in the selective degradation are proposed, based on the model-driven autophagy profiles such as the time evolution of autophagy fluxes, levels of autophagosomes/autolysosomes, and corresponding cellular changes. Further, with the help of the indices, those biological experiments of the target autophagy system have been successfully analyzed, implying that the indices are useful not only for defining autophagy activation but also for assessing its role in a specific and quantitative manner. Such quantitative autophagy indices in conjunction with the computer-aided analysis should provide new opportunities to characterize the causal relationship between autophagy activity and the corresponding cellular change, based on the system-level understanding of the autophagic process at good time resolution, complementing the current in vivo and in vitro assays.
    Full-text · Article · Jul 2014 · Theoretical Biology and Medical Modelling
  • Source
    • "Through these processes, cells can remove malfunctioning proteins and extend its lifespan. Autophagy can be regulated through mammalian target of rapamycin (mTOR) signaling pathway, and also can be upregulated by AMP-activated protein kinase (AMPK) and beclin-1 (Larsen and Sulzer, 2002; Hay and Sonenberg, 2004; Liang et al., 2007; Shin et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Autophagy is a series of catabolic process mediating the bulk degradation of intracellular proteins and organelles through formation of a double-membrane vesicle, known as an autophagosome, and fusing with lysosome. Autophagy plays an important role of death-survival decisions in neuronal cells, which may influence to several neurodegenerative disorders including Parkinson's disease. Chebulagic acid, the major constituent of Terminalia chebula and Phyllanthus emblica, is a benzopyran tannin compound with various kinds of beneficial effects. This study was performed to investigate the autophagy enhancing effect of chebulagic acid on human neuroblastoma SH-SY5Y cell lines. We determined the effect of chebulagic acid on expression levels of autophago-some marker proteins such as, DOR/TP53INP2, Golgi-associated ATPase Enhancer of 16 kDa (GATE 16) and Light chain 3 II (LC3 II), as well as those of its upstream pathway proteins, AMP-activated protein kinase (AMPK), mammalian target of rapamycin (mTOR) and Beclin-1. All of those proteins were modulated by chebulagic acid treatment in a way of enhancing the autophagy. Additionally in our study, chebulagic acid also showed a protective effect against 1-methyl-4-phenylpyridinium (MPP(+)) - induced cytotoxicity which mimics the pathological symptom of Parkinson's disease. This effect seems partially mediated by enhanced autophagy which increased the degradation of aggregated or misfolded proteins from cells. This study suggests that chebulagic acid is an attractive candidate as an autophagy-enhancing agent and therefore, it may provide a promising strategy to prevent or cure the diseases caused by accumulation of abnormal proteins including Parkinson's disease.
    Full-text · Article · Jul 2014 · Biomolecules and Therapeutics
Show more